Worth Asset Management, LLC - SUMMIT THERAPEUTICS PLC ownership

SUMMIT THERAPEUTICS PLC's ticker is SMMT and the CUSIP is 86627R102. A total of 5 filers reported holding SUMMIT THERAPEUTICS PLC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Worth Asset Management, LLC ownership history of SUMMIT THERAPEUTICS PLC
ValueSharesWeighting
Q4 2023$28,595
+39.6%
10,9560.0%0.02%
+17.6%
Q3 2023$20,488
-25.5%
10,9560.0%0.02%
-19.0%
Q2 2023$27,500
+66.2%
10,956
+15.9%
0.02%
+61.5%
Q1 2023$16,548
+29.8%
9,456
+215.2%
0.01%
+44.4%
Q4 2022$12,750
+218.8%
3,0000.0%0.01%
+200.0%
Q3 2022$4,000
+300.0%
3,000
+200.0%
0.00%
+200.0%
Q2 2022$1,0000.0%1,0000.0%0.00%0.0%
Q1 2022$1,0001,0000.00%
Other shareholders
SUMMIT THERAPEUTICS PLC shareholders Q1 2022
NameSharesValueWeighting ↓
LANSDOWNE PARTNERS (UK) LLP 1,596,666$2,858,0000.08%
Polar Capital LLP 300,000$537,0000.01%
Larson Financial Group LLC 654$1,0000.00%
ACADIAN ASSET MANAGEMENT LLC 173,385$310,0000.00%
Bank of New York Mellon Corp 216,897$388,0000.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 26,491$47,0000.00%
Parkside Financial Bank & Trust 398$1,0000.00%
DEUTSCHE BANK AG\ 200$00.00%
MORGAN STANLEY 227,960$408,0000.00%
Renaissance Technologies 112,106$201,0000.00%
View complete list of SUMMIT THERAPEUTICS PLC shareholders